Company / Current Assets per Share
ANI Pharmaceuticals, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$35.68
FY2025
5-year range
$21.17 / $35.68
FY2021-FY2025
Trend
+9.8%
vs FY2024
Sector context
#15 of 210
Health Care
What the data says
Among 210 Health Care companies, ANI Pharmaceuticals, Inc. is in the top 7% for current assets per share. Current Assets per Share has increased for 3 consecutive years, from $21.17 in FY2022 to $35.68 in FY2025.
Based on SEC 10-K filings.
35.68 in FY2025 with a 5-year CAGR of +20.2%. Top quartile in the Health Care sector.
Improved from $28.57 to $35.68 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +19.0%
- 5-Year CAGR
- +20.2%
- 10-Year CAGR
- -
Sector benchmark
-79.1% below sector average
Key checks
Key Insights
- ANI Pharmaceuticals, Inc.'s current assets per share has grown for 3 consecutive years.
- In FY2025, current assets per share increased 9.8% year-over-year.
- Ranks #15 out of 210 companies in the Health Care sector.
- Lowest current assets per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $35.68 | +9.8% |
| FY2024 | $32.50 | +13.8% |
| FY2023 | $28.57 | +34.9% |
| FY2022 | $21.17 | -17.1% |
| FY2021 | $25.55 | +79.4% |
| FY2020 | $14.24 | -12.4% |
| FY2019 | $16.25 | +25.2% |
| FY2018 | $12.99 | +14.0% |
| FY2017 | $11.39 | +27.9% |
| FY2016 | $8.90 | -100.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026